Arrowstreet Capital’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $234M | Sell |
1,975,559
-1,062,878
| -35% | -$131M | 0.13% | 152 |
|
|
2025
Q4 | $382M | Buy |
3,038,437
+340,610
| +13% | +$44.4M | 0.22% | 102 |
|
|
2025
Q3 | $395M | Buy |
2,697,827
+1,227,085
| +83% | +$185M | 0.25% | 80 |
|
|
2025
Q2 | $229M | Buy |
1,470,742
+822,334
| +127% | +$130M | 0.16% | 120 |
|
|
2025
Q1 | $107M | Buy |
648,408
+380,729
| +142% | +$63.3M | 0.09% | 216 |
|
|
2024
Q4 | $43.6M | Buy |
267,679
+248,131
| +1,269% | +$44.4M | 0.03% | 407 |
|
|
2024
Q3 | $3.82M | Buy |
+19,548
| New | +$3.6M | ﹤0.01% | 1040 |
|
|
2023
Q3 | – | Sell |
-152,498
| Closed | -$26.3M | – | 1451 |
|
|
2023
Q2 | $26.3M | Sell |
152,498
-25,808
| -14% | -$4.46M | 0.03% | 345 |
|
|
2023
Q1 | $29.7M | Sell |
178,306
-528,163
| -75% | -$86.6M | 0.04% | 343 |
|
|
2022
Q4 | $104M | Sell |
706,469
-305,345
| -30% | -$45.2M | 0.14% | 154 |
|
|
2022
Q3 | $150M | Sell |
1,011,814
-1,074,981
| -52% | -$180M | 0.22% | 117 |
|
|
2022
Q2 | $359M | Sell |
2,086,795
-1,239,653
| -37% | -$214M | 0.51% | 48 |
|
|
2022
Q1 | $627M | Buy |
3,326,448
+2,102,306
| +172% | +$416M | 0.78% | 27 |
|
|
2021
Q4 | $299M | Sell |
1,224,142
-191,942
| -14% | -$42M | 0.37% | 65 |
|
|
2021
Q3 | $275M | Buy |
1,416,084
+498,758
| +54% | +$101M | 0.34% | 58 |
|
|
2021
Q2 | $171M | Sell |
917,326
-244,019
| -21% | -$42.4M | 0.21% | 97 |
|
|
2021
Q1 | $183M | Buy |
1,161,345
+968,926
| +504% | +$154M | 0.24% | 78 |
|
|
2020
Q4 | $31.8M | Buy |
192,419
+187,690
| +3,969% | +$30.5M | 0.05% | 420 |
|
|
2020
Q3 | $782K | Sell |
4,729
-77,114
| -94% | -$11.8M | ﹤0.01% | 1888 |
|
|
2020
Q2 | $11.2M | Sell |
81,843
-251,186
| -75% | -$32.8M | 0.02% | 730 |
|
|
2020
Q1 | $39.2M | Buy |
+333,029
| New | +$43.8M | 0.11% | 175 |
|
|
2019
Q2 | – | Sell |
-724,109
| Closed | -$72.9M | – | 1751 |
|
|
2019
Q1 | $72.9M | Sell |
724,109
-303,215
| -30% | -$27.5M | 0.17% | 134 |
|
|
2018
Q4 | $87.9M | Buy |
1,027,324
+111,119
| +12% | +$10M | 0.23% | 105 |
|
|
2018
Q3 | $83.9M | Buy |
916,205
+591,125
| +182% | +$52.4M | 0.19% | 125 |
|
|
2018
Q2 | $27.7M | Buy |
325,080
+310,380
| +2,111% | +$26.2M | 0.07% | 259 |
|
|
2018
Q1 | $1.23M | Sell |
14,700
-525,347
| -97% | -$41.4M | ﹤0.01% | 829 |
|
|
2017
Q4 | $38.9M | Buy |
540,047
+375,347
| +228% | +$25.8M | 0.09% | 209 |
|
|
2017
Q3 | $10.5M | Buy |
164,700
+150,000
| +1,020% | +$9.4M | 0.03% | 369 |
|
|
2017
Q2 | $917K | Buy |
+14,700
| New | +$868K | ﹤0.01% | 799 |
|
|
2016
Q3 | – | Sell |
-71,200
| Closed | -$3.38M | – | 1665 |
|
|
2016
Q2 | $3.38M | Buy |
+71,200
| New | +$3.36M | 0.01% | 692 |
|
|
2015
Q4 | – | Sell |
-105,982
| Closed | -$4.36M | – | 1622 |
|
|
2015
Q3 | $4.36M | Sell |
105,982
-120,339
| -53% | -$5.58M | 0.02% | 568 |
|
|
2015
Q2 | $10.9M | Buy |
226,321
+196,300
| +654% | +$9.37M | 0.06% | 251 |
|
|
2015
Q1 | $1.39M | Buy |
+30,021
| New | +$1.35M | 0.01% | 656 |
|
Other funds holding ZTS
VCM
VPM
Arrowstreet Capital's ZTS Position: Q1 2026 in Review
Arrowstreet Capital reduced its Zoetis (ZTS) stake by 35% in Q1 2026, selling an estimated $131M and leaving 1,975,559 shares worth $234M. The position accounts for 0.13% of the portfolio, ranked #152.
Arrowstreet Capital first reported a position in ZTS in Q1 2015 and has held it in 33 quarters since. The position peaked at $627M in Q1 2022. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.
- Arrowstreet Capital held 1,975,559 shares of Zoetis worth $234M as of Q1 2026.
- Arrowstreet Capital sold 1,062,878 Zoetis shares in Q1 2026, an estimated $131M.
- Zoetis made up 0.13% of Arrowstreet Capital's portfolio in Q1 2026, its #152 holding.
- Arrowstreet Capital first reported a position in Zoetis in Q1 2015 and has held it in 33 quarters since.
- Arrowstreet Capital's Zoetis position peaked at $627M in Q1 2022.
- 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.